Skip to main content

Table 3 Result of Patient report outcome measures (PROM)

From: Patients with neuromyelitis optica spectrum disorder (NMOSD) are associated with adverse outcome after total hip arthroplasty: a matched case–control study

  HOOS-symptom HOOS-pain HOOS-ADL HOOS-SR HOOS-QOL HOOS  
Pre-operative
 NMO 54.17 ± 20.87 32.71 ± 2.42 27.33 ± 17.39 15.63 ± 15.19 9.38 ± 11.46 29.06 ± 13.94  
 Non-NMO 50.00 ± 21.52 40.63 ± 10.39 47.86 ± 15.20 26.82 ± 12.15 16.93 ± 17.04 41.12 ± 13;82  
 P value 0.584 0.249 0.001 0.022 0.269 0.019  
Post-operative
 NMO 94.17 ± 9.96 95.83 ± 6.34 90.69 ± 8.42 71.35 ± 25.90 72.40 ± 26.04 81.70 ± 2.16  
 Non-NMO 88.33 ± 10.39 92.92 ± 7.86 94.61 ± 7.74 84.64 ± 0.21 82.55 ± 13.16 82.79 ± 1.84  
 P value 0.141 0.210 0.596 0.163 0.269 0.538  
  EQ-mobility EQ-self care EQ-usual activity EQ-pain EQ-anxiety EQ-VAS VAS
Pre-operative
 NMO 4.42 ± 0.67 3.71 ± 0.62 4.42 ± 0.67 4.08 ± 0.99 4.08 ± 0.99 30.58 ± 13.37 8.17 ± 2.08
 Non-NMO 1.54 ± 0.17 1.19 ± 0.08 1.37 ± 0.14 1.42 ± 0.15 3.67 ± 0.48 49.79 ± 16.36 7.79 ± 1.69
 P value 0.004 0.123  < 0.001 0.322 0.097 0.001 0.565
Post-operative
 NMO 1.92 ± 1.16 1.25 ± 0.45 2.08 ± 0.79 1.92 ± 1.08 1.67 ± 0.98 71.67 ± 16.97 1.25 ± 2.38
 Non-NMO 1.46 ± 0.58 1.17 ± 0.38 1.38 ± 0.49 1.42 ± 0.50 1.21 ± 0.41 88.00 ± 9.30 1.00 ± 0.93
 P value 0.496 0.871 0.014 0.088 0.071 0.035 0.698